Honorary Professor

Grant Ramm

Email: 

Availability

Honorary Professor Grant Ramm is:
Available for supervision

Fields of research

Clinical sciences

Qualifications

  • Bachelor (Honours), The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Search Professor Grant Ramm’s works on UQ eSpace

184 works between 1985 and 2024
All (184) Journal Article (141) Conference Publication (43)

1 - 20 of 184 works

2024

Journal Article

A maternal high-fat diet predisposes to infant lung disease via increased neutrophil-mediated IL-6 trans-signaling

Curren, Bodie, Ahmed, Tufael, Rashid, Ridwan B., Sebina, Ismail, Al Amin Sikder, Md., Howard, Daniel R., Alorro, Mariah, Ullah, Md. Ashik, Bissell, Alec, Rahman, Muhammed Mahfuzur, Pearen, Michael A., Ramm, Grant A., Varelias, Antiopi, Rose-John, Stefan, MacDonald, Kelli P. A., Hoelzle, Robert, Ó Cuív, Páraic, Spann, Kirsten M., Dennis, Paul G. and Phipps, Simon (2024). A maternal high-fat diet predisposes to infant lung disease via increased neutrophil-mediated IL-6 trans-signaling. Cell Reports, 43 (11) 114974, 114974. doi: 10.1016/j.celrep.2024.114974

A maternal high-fat diet predisposes to infant lung disease via increased neutrophil-mediated IL-6 trans-signaling

2024

Journal Article

Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis

Sajiir, Haressh, Wong, Kuan Yau, Müller, Alexandra, Keshvari, Sahar, Burr, Lucy, Aiello, Elena, Mezza, Teresa, Giaccari, Andrea, Sebastiani, Guido, Dotta, Francesco, Ramm, Grant A., Macdonald, Graeme A., McGuckin, Michael A., Prins, Johannes B. and Hasnain, Sumaira Z. (2024). Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis. Nature Communications, 15 (1) 4527, 1-12. doi: 10.1038/s41467-024-48320-2

Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis

2024

Journal Article

Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis

Sajiir, Haressh, Keshvari, Sahar, Wong, Kuan Yau, Borg, Danielle J., Steyn, Frederik J., Fercher, Christian, Taylor, Karin, Taylor, Breten, Barnard, Ross T., Müller, Alexandra, Moniruzzaman, Md, Miller, Gregory, Wang, Ran, Fotheringham, Amelia, Schreiber, Veronika, Sheng, Yong Hua, Hancock, Janelle Louise, Loo, Dorothy, Burr, Lucy, Huynh, Tony, Lockett, Jack, Ramm, Grant A., Macdonald, Graeme A., Prins, Johannes B., McGuckin, Michael A. and Hasnain, Sumaira Z. (2024). Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis. Nature Communications, 15 (1) 4528, 4528. doi: 10.1038/s41467-024-48317-x

Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis

2024

Journal Article

The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation

Fernandez-Rojo, Manuel A., Pearen, Michael A., Burgess, Anita G., Ikonomopoulou, Maria P., Hoang-Le, Diem, Genz, Berit, Saggiomo, Silvia L., Nawaratna, Sujeevi S. K., Poli, Maura, Reissmann, Regina, Gobert, Geoffrey N., Deutsch, Urban, Engelhardt, Britta, Brooks, Andrew J., Jones, Alun, Arosio, Paolo and Ramm, Grant A. (2024). The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation. Science Signaling, 17 (830) eade4335, 1-16. doi: 10.1126/scisignal.ade4335

The heavy subunit of ferritin stimulates NLRP3 inflammasomes in hepatic stellate cells through ICAM-1 to drive hepatic inflammation

2024

Journal Article

Extrahepatic iron loading associates with the propensity to develop advanced hepatic fibrosis in hemochromatosis

Olynyk, John K., St. Pierre, Timothy G., Chen, James, Frazer, David M., Ramm, Louise E. and Ramm, Grant A. (2024). Extrahepatic iron loading associates with the propensity to develop advanced hepatic fibrosis in hemochromatosis. Gastro Hep Advances, 3 (4), 454-460. doi: 10.1016/j.gastha.2024.01.011

Extrahepatic iron loading associates with the propensity to develop advanced hepatic fibrosis in hemochromatosis

2023

Journal Article

The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis

Olynyk, John K., Grainger, Richard, Currie, Helen, Ramm, Louise E. and Ramm, Grant A. (2023). The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis. Scientific Reports, 13 (1) 7775, 1-6. doi: 10.1038/s41598-023-35028-4

The ancestral haplotype markers HLA -A3 and B7 do not influence the likelihood of advanced hepatic fibrosis or cirrhosis in HFE hemochromatosis

2023

Journal Article

Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers

Balaji, Arunpandian, Bell, Craig A., Houston, Zachary H., Bridle, Kim R., Genz, Berit, Fletcher, Nicholas L., Ramm, Grant A. and Thurecht, Kristofer J. (2023). Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers. Biomaterials, 302 122318, 1-18. doi: 10.1016/j.biomaterials.2023.122318

Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers

2023

Journal Article

Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy

Sakhuja, Shruti, Staples, Heather M., Minard, Charles G., Ramm, Louise E., Lewindon, Peter J., Ramm, Grant A. and Leung, Daniel H. (2023). Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy. Liver International, 43 (6), 1277-1286. doi: 10.1111/liv.15572

Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis-related liver disease: A multi-center study validated by liver biopsy

2023

Journal Article

Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver

Crawford, Darrell H. G., Ramm, Grant A., Bridle, Kim R., Nicoll, Amanda J., Delatycki, Martin B. and Olynyk, John K. (2023). Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver. Hepatology International, 17 (3), 522-541. doi: 10.1007/s12072-023-10510-3

Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver

2023

Journal Article

TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic Pancreatitis

Abu Bakar, N. Dianah B., Carlessi, Rodrigo, Gogoi-Tiwari, Jully, Köhn-Gaone, Julia, Williams, Vincent, Falasca, Marco, Olynyk, John K., Ramm, Grant A. and Tirnitz-Parker, Janina E. E. (2023). TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic Pancreatitis. Cancers, 15 (6) 1807, 1-15. doi: 10.3390/cancers15061807

TWEAK/Fn14 Signalling Regulates the Tissue Microenvironment in Chronic Pancreatitis

2022

Journal Article

Building a case for pancreas and liver targeted intereukin-22 therapy in fatty liver disease

Sajiir, Haressh, Wong, Kuan Yau, Mueller, Alexandra, Keshvari, Sahar, Wang, Ran, Wiid, Percival, Ramm, Grant, Macdonald, Graeme, Prins, John, McGuckin, Michael and Hasnain, Sumaira (2022). Building a case for pancreas and liver targeted intereukin-22 therapy in fatty liver disease. Journal of Hepatology, 77 (Supplement 1), S190-S191. doi: 10.1016/s0168-8278(22)00756-5

Building a case for pancreas and liver targeted intereukin-22 therapy in fatty liver disease

2022

Journal Article

Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells

Carson, Jack P., Robinson, Mark W., Ramm, Grant A. and Gobert, Geoffrey N. (2022). Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells. Experimental Parasitology, 236-237 108255, 108255. doi: 10.1016/j.exppara.2022.108255

Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells

2022

Journal Article

Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis

Calvopina, Diego A., Lewindon, Peter J., Ramm, Louise E., Noble, Charlton, Hartel, Gunter F., Leung, Daniel H and Ramm, Grant A. (2022). Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis. Journal of Cystic Fibrosis, 21 (2), 236-242. doi: 10.1016/j.jcf.2021.10.014

Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis

2022

Journal Article

Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: a 27-year real-life cohort study

Baldissera, Marilisa, Lewindon, Peter J., Ramm, Louise E., Hartel, Gunter F., Mattiello, Rita and Ramm, Grant A. (2022). Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: a 27-year real-life cohort study. Journal of Cystic Fibrosis, 21 (2), 230-235. doi: 10.1016/j.jcf.2021.11.015

Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: a 27-year real-life cohort study

2022

Journal Article

Therapeutic potential of macrophage colony-stimulating factor (CSF1) in chronic liver disease

Keshvari, Sahar, Genz, Berit, Teakle, Ngari, Caruso, Melanie, Cestari, Michelle F., Patkar, Omkar L., Tse, Brian W. C., Sokolowski, Kamil A., Ebersbach, Hilmar, Jascur, Julia, MacDonald, Kelli P. A., Miller, Gregory, Ramm, Grant A., Pettit, Allison R., Clouston, Andrew D., Powell, Elizabeth E., Hume, David A. and Irvine, Katharine M. (2022). Therapeutic potential of macrophage colony-stimulating factor (CSF1) in chronic liver disease. Disease Models and Mechanisms, 15 (4) dmm049387, 1-15. doi: 10.1242/dmm.049387

Therapeutic potential of macrophage colony-stimulating factor (CSF1) in chronic liver disease

2022

Journal Article

Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis

Andersson, Lauren, Powell, Lawrie W., Ramm, Louise E., Ramm, Grant A. and Olynyk, John K. (2022). Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis. Mayo Clinic Proceedings, 97 (9), 1649-1655. doi: 10.1016/j.mayocp.2022.02.017

Arthritis Prediction of Advanced Hepatic Fibrosis in HFE Hemochromatosis

2021

Journal Article

Risk of Liver Cancer in HFE-Hemochromatosis

Olynyk, John K. and Ramm, Grant A. (2021). Risk of Liver Cancer in HFE-Hemochromatosis. Gastroenterology, 161 (5), 1718-1719. doi: 10.1053/j.gastro.2021.08.025

Risk of Liver Cancer in HFE-Hemochromatosis

2021

Journal Article

RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation

Carson, Jack P., Robinson, Mark W., Ramm, Grant A. and Gobert, Geoffrey N. (2021). RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation. Molecular Biology Reports, 48 (12), 7677-7688. doi: 10.1007/s11033-021-06774-3

RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation

2021

Journal Article

Cost-effectiveness of a serum biomarker test for risk-stratified liver ultrasound screening for hepatocellular carcinoma

Carter, Hannah E., Jeffrey, Gary P., Ramm, Grant A. and Gordon, Louisa G. (2021). Cost-effectiveness of a serum biomarker test for risk-stratified liver ultrasound screening for hepatocellular carcinoma. Value in Health, 24 (10), 1454-1462. doi: 10.1016/j.jval.2021.04.1286

Cost-effectiveness of a serum biomarker test for risk-stratified liver ultrasound screening for hepatocellular carcinoma

2021

Journal Article

The role of sonic hedgehog in human holoprosencephaly and short-rib polydactyly syndromes

Loo, Christine K. C., Pearen, Michael A. and Ramm, Grant A. (2021). The role of sonic hedgehog in human holoprosencephaly and short-rib polydactyly syndromes. International Journal of Molecular Sciences, 22 (18) 9854, 9854. doi: 10.3390/ijms22189854

The role of sonic hedgehog in human holoprosencephaly and short-rib polydactyly syndromes

Past funding

  • 2018 - 2020
    Tissue ferritin is a damage-associated molecular pattern (DAMP) in inflammasome-induced inflammation associated with hepatic stellate cell activation and ... (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2016 - 2020
    SARA: Delineating its Association with the Onset and Development of Liver Fibrosis (NHMRC Project Grant led by Queensland University of Technology)
    Queensland University of Technology
    Open grant

Availability

Honorary Professor Grant Ramm is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Completed supervision

Enquiries

For media enquiries about Honorary Professor Grant Ramm's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au